Olmesartán Medoxomilo
C29H30N6O6
558,59
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methyl ethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
1-{[2′-(1H-Tetrazol-5-il)bifenil-4-il]-4-(2-hidroxipropan-2-il)-2-propil-1H-imidazol-5-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metilo [144689-63-4]
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methyl ethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
1-{[2′-(1H-Tetrazol-5-il)bifenil-4-il]-4-(2-hidroxipropan-2-il)-2-propil-1H-imidazol-5-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metilo [144689-63-4]
DEFINICIÓN
El Olmesartán Medoxomilo contiene no menos de 98,5% y no más de 101,5% de C29H30N6O6, calculado con respecto a la sustancia anhidra y exenta de disolvente.
ESTÁNDARES DE REFERENCIA USP A LA VENTA
ER Compuesto Relacionado A de Olmesartán Medoxomilo USPER Olmesartán Medoxomilo USP